RPS backs changes to interval between COVID-19 vaccination doses

The Royal Pharmaceutical Society has said it strongly supports changes to the planned interval between currently licensed COVID-19 vaccine doses in the UK.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research